Shifting paradigms in the pharmacogenetics of warfarin.

about

Genetic and environmental factors determining clinical outcomes and cost of warfarin therapy: a prospective study.Translational and clinical applications of salivary diagnostics.Novel CYP2C9 and VKORC1 gene variants associated with warfarin dosage variability in the South African black population.

P2860

Q35900767-86A5331C-1593-4FD5-9435-A00D44C63E27 Q38415643-5028A637-8904-405D-A36C-DF6968B6F2C8 Q42733103-E05D6C57-1FA5-4084-B812-0FDB4E313369

P2860

Shifting paradigms in the pharmacogenetics of warfarin.

Item

http://www.wikidata.org/entity/Q46316268

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Shifting paradigms in the pharmacogenetics of warfarin.

@en

Shifting paradigms in the pharmacogenetics of warfarin.

@nl

type

Item

label

Shifting paradigms in the pharmacogenetics of warfarin.

@en

Shifting paradigms in the pharmacogenetics of warfarin.

@nl

prefLabel

Shifting paradigms in the pharmacogenetics of warfarin.

@en

Shifting paradigms in the pharmacogenetics of warfarin.

@nl

P1476

Shifting paradigms in the pharmacogenetics of warfarin.

@en

P2093

Eva Gak

http://www.w3.org/2001/XMLSchema#string

Hillel Halkin

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2

Identification of the gene for vitamin K epoxide reductase

Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose.

Warfarin pharmacogenetics: CYP2C9 and VKORC1 genotypes predict different sensitivity and resistance frequencies in the Ashkenazi and Sephardi Jewish populations.

Genetic determinants of response to warfarin during initial anticoagulation

Association of warfarin dose with genes involved in its action and metabolism.

Oral anticoagulants: Pharmacogenetics Relationship between genetic and non-genetic factors.

VKORC1: a warfarin-sensitive enzyme in vitamin K metabolism and biosynthesis of vitamin K-dependent blood coagulation factors.

Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans.

P304

1373-1375

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.2217/14622416.9.10.1373

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18855523

http://www.w3.org/2001/XMLSchema#string

Shifting paradigms in the pharmacogenetics of warfarin.

about

P2860

P2860

Shifting paradigms in the pharmacogenetics of warfarin.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698